GABAA Receptor Channel Pharmacology
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1867-1885
Author(s):
Graham A.R. Johnston
Ubiquitin-Proteasome Pathway Components as Therapeutic Targets for CNS Maladies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3807-3828
Author(s):
S. C. Upadhya and A. N. Hegde
Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?
Journal:
Current Pediatric Reviews
Volume:
2
Page:
143-153
Author(s):
Virginia C.N. Wong and Brian H.Y. Chung
Stem Cell Pharmacogenomics
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1369-1381
Author(s):
S. A. Bapat and G. C. Mishra
Drosophila melanogaster in the Study of Human Neurodegeneration
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
504-523
Author(s):
Frank Hirth
Targeting Protein Degradation in the Nervous System
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
285-306
Author(s):
Jason J. Yi and Michael D. Ehlers
Ubiquitination in Rho Signaling
Journal:
Current Topics in Medicinal Chemistry
Volume:
11
Page:
2879-2887
Author(s):
Feng Ding, Zhenyu Yin and Hong-Rui Wang
Disorders of Protein Biogenesis and Stability
Journal:
Protein & Peptide Letters
Volume:
18
Page:
110-121
Author(s):
John F. Anderson, Efrain Siller and Jose M. Barral
Genome-Scale Technologies Foster Advances in Neurological and Behavioral Research
Journal:
Current Psychiatry Reviews
Volume:
6
Page:
74-81
Author(s):
Steve Rozen
Unfoldomics of Human Genetic Diseases: Illustrative Examples of Ordered and Intrinsically Disordered Members of the Human Diseasome
Journal:
Protein & Peptide Letters
Volume:
16
Page:
1533-1547
Author(s):
Uros Midic, Christopher J. Oldfield, A. Keith Dunker, Zoran Obradovic and Vladimir N. Uversky